Protein Engineering Market Likely To Reach $3.09 Billion By 2025: Grand View Research, Inc.

Posted on 2019-01-10 by researchinsights in Biotech // 0 Comments

San Francisco, United States, 2019-Jan-10 — /EPR Network/ —

The global protein engineering market is expected to reach USD 3.09 billion by 2025, according to a new report by Grand View Research, Inc. The market is driven by presence of regulatory authorities consistently striving to reduce time and cost involved in the drug discovery process. One such example is the launch of critical path initiative by U.S. FDA, for incorporation of advanced technologies, such as protein engineering, in drug discovery processes. Moreover, this facilitates prediction of probable adverse reactions & toxicity and improves efficacy of target molecules early on, resulting in lowered drug attrition rates in the later stages. This is anticipated to help control overall expenditure. Rise in R&D expenditure by countries indicates the urgent need for adoption of these tools in all drug discovery and development processes.

The rising number of government initiatives aimed at enhancing protein engineering capabilities is anticipated to present the market with high growth potential. This has resulted in a significant rise in number of research activities & programs and fund allotment for R&D. For instance, Protein Engineering Network of Centres of Excellence (PENCE) contributed approximately USD 1.0 million for proteomics projects and hosted conferences on proteomics in Canada as an effort to broaden research associated with this technology.

To request a sample copy of this report, click the link below:
www.grandviewresearch.com/industry-analysis/protein-engineering-market

U.S. protein engineering market by technology, 2014 – 2025 (USD Million)

U.S. protein engineering market

Further Key Findings From the Report Suggest:

Hybrid approach is predicted to observe exponential growth as a consequence of technological superiority and ability to overcome the shortcomings associated with the aforementioned technologies
Software & services is expected to emerge as the fastest growing segment owing to high inclination of companies to outsourcing of services to achieve overall cost-efficiency
Monoclonal antibodies held the largest share in protein-type segment due to development of these antibodies on a large scale through extensive adoption of these engineering tools
North America held a substantial share, which can be attributed to extensive research activities that are likely to provide high potential growth platform through consistent usage in this region
The market in Asia Pacific is projected to exhibit exponential growth over the coming years owing to rising awareness pertaining to benefits of protein engineering and increasing disposable income
The competition is marked by players employing strategies such as mergers & acquisitions and distribution agreements resulting in significant growth in their market share

Related Report of Biotechnology:

Grand View Research has segmented the global protein engineering market on the basis of technology, product, protein type, end-use, and region:

Technology Outlook (Revenue, USD Million, 2014 – 2025)

Rational Protein Design
Directed Evolution
Hybrid Approach

Product Outlook (Revenue, USD Million, 2014 – 2025)

Instruments
Reagents
Software & Services

Protein Type Outlook (Revenue, USD Million, 2014 – 2025)

Insulin
Monoclonal Antibodies
Vaccines
Growth Factors
Colony Stimulating Factors
Coagulation Factors
Interferon
Others

End-use Outlook (Revenue, USD Million, 2014 – 2025)

Academic Research Institutes
CROs
Pharma & Biotech Companies

Regional Outlook (Revenue, USD Million, 2014 – 2025)

North America
- U.S.
- Canada
Europe
- UK
- Germany
Asia Pacific
- Japan
- China
- India
Latin America
- Mexico
- Brazil
Middle East & Africa
- South Africa

Access Press Release Of This Research Report by Grand View Research: www.grandviewresearch.com/press-release/global-protein-engineering-market

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

Matched content

Editor’s pick